关键词:非免疫原性肿瘤 B7-1基因 干扰素-γ 基因表达 基因,MHC I类
【摘要】 目的 探索非免疫原性肿瘤的免疫基因治疗。方法 将B7-1基因导入非免疫原性肿瘤细胞B16,在体外经IFN-γ处理后,观察细胞表面分子的表达变化,以及肿瘤细胞在小鼠体内的成瘤性。结果 单独B7基因转导的B7+ B16在小鼠体内持续生长。体外用IFN-γ处理肿瘤细胞,可明显增加细胞表面MHC I类分子的表达,与B7- B16比较,B7+ B16在小鼠体内的成瘤性明显降低。结论单独B7基因导入并表达,不能改变B16在体内恶性增殖的特性。同时提高细胞表面B7与MHC I分子的表达,两者可协同发挥作用,诱发肿瘤排斥。
Rejection of non-immunogenic tumor cells transfected with costimulatory molecule B7 after treatment with IFN-γ in vitro Zheng Shuling, Zhang Shuren, Wang Dongmei, et al. Cancer Institute(Hospital), Chinese Academy of medical Sciences, Peking Union Medical College, Beijing 100021
【Abstract】 Objective To explore immuno-gene-therapy of non-immunogenic tumor. Methods Non-immurogenic tumor cells B16 were transfected with B7-1 gene. The B7-1 gene transfected B16 cells (B7+ B16) were treated with recombinant murine interferon-gamma (rmIFN-γ) in vitro, and then inoculated to C57BL/6 mice. Results While B7+ B16 cells grew progressively in syngeneic mice, tumorigenicty was significantly reduced when B7+ B16 cells were treated with rmIFN-γ before inoculation to mice. Flow cytometric analysis of the rmIFN-γ treated B7+ B16 cells showed significant up-regulation of MHC classⅠexpression. Conclusion For non-immunogenic tumor if the expressions of MHC class I molecules is low, providing co-stimulatory molecule B7 is not enough to reduce tumorigenicity. The B7-1 gene transfected B16 cells become non-tumorigenic or weakly tumorigenic when their MHC class I is up-regulated.
......
您现在查看是摘要页,全文长 12288 字符。